Medigen Biotechnology Revenue

Medigen Biotechnology had revenue of 499.37M TWD in the quarter ending March 31, 2025, with 98.70% growth. This brings the company's revenue in the last twelve months to 1.62B, up 30.20% year-over-year. In the year 2024, Medigen Biotechnology had annual revenue of 1.37B with 18.57% growth.

Revenue (ttm)

1.62B

Revenue Growth

+30.20%

P/S Ratio

2.68

Revenue / Employee

n/a

Employees

n/a

Market Cap

4.34B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.37B	214.98M	18.57%
Dec 31, 2023	1.16B	101.77M	9.64%
Dec 31, 2022	1.06B	-2.87B	-73.08%
Dec 31, 2021	3.92B	3.31B	537.17%
Dec 31, 2020	615.54M	63.20M	11.44%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	11.34B
Caliway Biopharmaceuticals	40.47M
Bora Pharmaceuticals Co., LTD.	20.87B
Lotus Pharmaceutical	19.12B
Polaris Group	107.00M
Oneness Biotech	117.33M
Pegavision	6.69B
Center Laboratories	1.63B

Revenue Rankings